T1	Participants 294 336	Twenty patients who received 4 days of TBI
T2	Participants 58 168	oral ondansetron in the prevention of nausea and vomiting associated with fractionated total-body irradiation.
T3	Participants 228 285	total-body irradiation (TBI)-induced nausea and vomiting.
